{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:47:27Z","timestamp":1761155247910},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10147-008-0795-x","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T04:32:27Z","timestamp":1235017947000},"page":"37-42","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medical treatment of cervical intraepithelial neoplasia II, III: an update review"],"prefix":"10.1007","volume":"14","author":[{"given":"Chumnan","family":"Kietpeerakool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatupol","family":"Srisomboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,20]]},"reference":[{"key":"795_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"J.M. Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"795_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N. Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"795_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"A.G. Ostor","year":"1993","unstructured":"Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186\u2013192","journal-title":"Int J Gynecol Pathol"},{"key":"795_CR4","first-page":"619","volume":"3","author":"M.F. Mitchell","year":"1994","unstructured":"Mitchell MF, Hittelman WN, Hong WK, et al. (1994) The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 3:619\u2013626","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","volume":"197","author":"T.C. Wright Jr.","year":"2007","unstructured":"Wright TC, Jr., Massad LS, Dunton CJ, et al. (2007) 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 197:340\u2013345","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl3","key":"795_CR6","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","volume":"24","author":"A.B. Moscicki","year":"2006","unstructured":"Moscicki AB, Schiffman M, Kjaer S, et al. (2006) Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24(Suppl 3):S42\u2013S51","journal-title":"Vaccine"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1447-0756.2007.00528.x","volume":"33","author":"C. Kietpeerakool","year":"2007","unstructured":"Kietpeerakool C, Srisomboon J, Suprasert P, et al. (2007) Routine prophylactic application of Monsel\u2019s solution after loop electrosurgical excision procedure of the cervix: is it necessary? J Obstet Gynaecol Res 33:299\u2013304","journal-title":"J Obstet Gynaecol Res"},{"key":"795_CR8","first-page":"711","volume":"36","author":"P.A. Hillard","year":"1991","unstructured":"Hillard PA, Biro FM, Wildey L (1991) Complications of cervical cryotherapy in adolescents. J Reprod Med 36:711\u2013716","journal-title":"J Reprod Med"},{"key":"795_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.AOG.0000253239.87040.23","volume":"109","author":"M. Jakobsson","year":"2007","unstructured":"Jakobsson M, Gissler M, Sainio S, et al. (2007) Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 109:309\u2013313","journal-title":"Obstet Gynecol"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/gyno.2000.5847","volume":"78","author":"M.C. Bell","year":"2000","unstructured":"Bell MC, Crowley-Nowick P, Bradlow HL, et al. (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123\u2013129","journal-title":"Gynecol Oncol"},{"key":"795_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ygyno.2004.12.020","volume":"97","author":"Y. Dai","year":"2005","unstructured":"Dai Y, Zhang X, Peng Y, et al. (2005) The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol Oncol 97:96\u2013103","journal-title":"Gynecol Oncol"},{"key":"795_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1525-1438.2007.00798.x","volume":"17","author":"P. Dursun","year":"2007","unstructured":"Dursun P, Yuce K, Usubutun A, et al. (2007) Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. Int J Gynecol Cancer 17:164\u2013173","journal-title":"Int J Gynecol Cancer"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ygyno.2004.08.002","volume":"95","author":"J.S. Lee","year":"2004","unstructured":"Lee JS, Choi YD, Lee JH, et al. (2004) Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth. Gynecol Oncol 95: 523\u2013529","journal-title":"Gynecol Oncol"},{"key":"795_CR14","first-page":"293","volume":"60","author":"B.S. Reddy","year":"2000","unstructured":"Reddy BS, Hirose Y, Lubet R, et al. (2000) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293\u2013297","journal-title":"Cancer Res"},{"key":"795_CR15","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2551::AID-CNCR12>3.0.CO;2-1","volume":"86","author":"E. Hawk","year":"1999","unstructured":"Hawk E, Lubet R, Limburg P (1999) Chemoprevention in hereditary colorectal cancer syndromes. Cancer 86:2551\u20132563","journal-title":"Cancer"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ygyno.2006.03.036","volume":"103","author":"J.H. Farley","year":"2006","unstructured":"Farley JH, Truong V, Goo E, et al. (2006) A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor celecoxib in the treatment of cervical dysplasia. Gynecol Oncol 103:425\u2013430","journal-title":"Gynecol Oncol"},{"key":"795_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejogrb.2005.08.019","volume":"125","author":"L.A. Hefler","year":"2006","unstructured":"Hefler LA, Grimm C, Speiser P, et al. (2006) The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial. Eur J Obstet Gynecol Reprod Biol 125:251\u2013254","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"795_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"S.D. Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA, et al. (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071\u20131080","journal-title":"N Engl J Med"},{"key":"795_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"R.S. Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, et al. (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102","journal-title":"N Engl J Med"},{"key":"795_CR20","first-page":"1383","volume":"4","author":"I.V. Boiko","year":"1998","unstructured":"Boiko IV, Mitchell MF, Hu W, et al. (1998) Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial. Clin Cancer Res 4:1383\u20131391","journal-title":"Clin Cancer Res"},{"key":"795_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrc1454","volume":"4","author":"E.W. Gerner","year":"2004","unstructured":"Gerner EW, Meyskens FL Jr (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4:781\u2013792","journal-title":"Nat Rev Cancer"},{"key":"795_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1582-4934.2005.tb00493.x","volume":"9","author":"N. Seiler","year":"2005","unstructured":"Seiler N, Raul F (2005) Polyamines and apoptosis. J Cell Mol Med 9:623\u2013642","journal-title":"J Cell Mol Med"},{"key":"795_CR23","first-page":"303","volume":"4","author":"M.F. Mitchell","year":"1998","unstructured":"Mitchell MF, Tortolero-Luna G, Lee JJ, et al. (1998) Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clin Cancer Res 4:303\u2013310","journal-title":"Clin Cancer Res"},{"key":"795_CR24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1078-0432.390.11.1","volume":"11","author":"A.T. Vlastos","year":"2005","unstructured":"Vlastos AT, West LA, Atkinson EN, et al. (2005) Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3. Clin Cancer Res 11:390\u2013396","journal-title":"Clin Cancer Res"},{"key":"795_CR25","first-page":"1315","volume":"66","author":"F.L. Meyskens Jr","year":"1982","unstructured":"Meyskens FL Jr, Gilmartin E, Alberts DS, et al. (1982) Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 66:1315\u20131319","journal-title":"Cancer Treat Rep"},{"key":"795_CR26","first-page":"921","volume":"71","author":"F.L. Meyskens Jr","year":"1983","unstructured":"Meyskens FL Jr, Graham V, Chvapil M, et al. (1983) A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst 71:921\u2013925","journal-title":"J Natl Cancer Inst"},{"key":"795_CR27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0002-9378(82)90016-3","volume":"143","author":"E.A. Surwit","year":"1982","unstructured":"Surwit EA, Graham V, Droegemueller W, et al. (1982) Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions. Am J Obstet Gynecol 143:821\u2013823","journal-title":"Am J Obstet Gynecol"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF00179590","volume":"4","author":"S.A. Weiner","year":"1986","unstructured":"Weiner SA, Surwit EA, Graham VE, et al. (1986) A phase I trial of topically applied trans-retinoic acid in cervical dysplasia \u2014 clinical efficacy. Invest New Drugs 4:241\u2013244","journal-title":"Invest New Drugs"},{"key":"795_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jnci\/86.7.539","volume":"86","author":"F.L. Meyskens Jr","year":"1994","unstructured":"Meyskens FL Jr, Surwit E, Moon TE, et al. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 86:539\u2013543","journal-title":"J Natl Cancer Inst"},{"key":"795_CR30","first-page":"3356","volume":"7","author":"M. Follen","year":"2001","unstructured":"Follen M, Atkinson EN, Schottenfeld D, et al. (2001) A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res 7:3356\u20133365","journal-title":"Clin Cancer Res"},{"key":"795_CR31","first-page":"114","volume":"12","author":"R.D. Alvarez","year":"2003","unstructured":"Alvarez RD, Conner MG, Weiss H, et al. (2003) The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial. Cancer Epidemiol Biomarkers Prev 12:114\u2013119","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR32","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.2148.13.12","volume":"13","author":"M.T. Ruffin","year":"2004","unstructured":"Ruffin MT, Bailey JM, Normolle DP, et al. (2004) Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III. Cancer Epidemiol Biomarkers Prev 13: 2148\u20132152","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR33","first-page":"CD003296","volume":"4","author":"CW Helm","year":"2007","unstructured":"Helm CW, Lorenz DJ, Meyer NJ, et al. (2007) Retinoids for preventing the progression of cervical intra-epithelial neoplasia. Cochrane Database Syst Rev 4:CD003296","journal-title":"Cochrane Database Syst Rev"},{"key":"795_CR34","first-page":"526","volume":"18","author":"A. Kwasniewska","year":"2997","unstructured":"Kwasniewska A, Tukendorf A, Semczuk M (2997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18:526\u2013530","journal-title":"Eur J Gynaecol Oncol"},{"key":"795_CR35","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1158\/0008-5472.CAN-04-2402","volume":"64","author":"C.J. Piyathilake","year":"2004","unstructured":"Piyathilake CJ, Henao OL, Macaluso M, et al. (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788\u20138793","journal-title":"Cancer Res"},{"key":"795_CR36","first-page":"353","volume":"11","author":"R.L. Sedjo","year":"2002","unstructured":"Sedjo RL, Inserra P, Abrahamsen M, et al. (2002) Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11:353\u2013359","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.nut.2006.12.002","volume":"23","author":"C.J. Piyathilake","year":"2007","unstructured":"Piyathilake CJ, Macaluso M, Brill I, et al. (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23:203\u2013210","journal-title":"Nutrition"},{"key":"795_CR38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0002-9378(92)91337-A","volume":"166","author":"C.E. Butterworth Jr","year":"1992","unstructured":"Butterworth CE Jr, Hatch KD, Soong SJ, et al. (1992) Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 166:803\u2013809","journal-title":"Am J Obstet Gynecol"},{"key":"795_CR39","first-page":"155","volume":"4","author":"J.M. Childers","year":"1995","unstructured":"Childers JM, Chu J, Voigt LF, et al. (1995) Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study. Cancer Epidemiol Biomarkers Prev 4:155\u2013159","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR40","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/0002-9378(92)91794-B","volume":"167","author":"P.R. Palan","year":"1992","unstructured":"Palan PR, Mikhail MS, Basu J, et al. (1992) Beta-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol 167: 1899\u20131903","journal-title":"Am J Obstet Gynecol"},{"key":"795_CR41","first-page":"929","volume":"5","author":"A. Manetta","year":"1996","unstructured":"Manetta A, Schubbert T, Chapman J, et al. (1996) Beta-carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol Biomarkers Prev 5:929\u2013932","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1006\/gyno.1997.4697","volume":"65","author":"S.L. Romney","year":"1997","unstructured":"Romney SL, Ho GY, Palan PR, et al. (1997) Effects of betacarotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 65:483\u2013492","journal-title":"Gynecol Oncol"},{"key":"795_CR43","first-page":"1029","volume":"10","author":"K.A. Keefe","year":"2001","unstructured":"Keefe KA, Schell MJ, Brewer C, et al. (2001) A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 10:1029\u20131035","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"795_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/carcin\/12.9.1571","volume":"12","author":"H.L. Bradlow","year":"1991","unstructured":"Bradlow HL, Michnovicz J, Telang NT, et al. (1991) Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571\u20131574","journal-title":"Carcinogenesis"},{"key":"795_CR45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4757-3230-6_14","volume":"472","author":"G. van Poppel","year":"1999","unstructured":"van Poppel G, Verhoeven DT, Verhagen H, et al. (1999) Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 472:159\u2013168","journal-title":"Adv Exp Med Biol"},{"key":"795_CR46","first-page":"89","volume":"13","author":"V.P. Garikapaty","year":"2005","unstructured":"Garikapaty VP, Ashok BT, Chen YG, et al. (2005) Anticarcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncol Rep 13:89\u201393","journal-title":"Oncol Rep"},{"key":"795_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bbrc.2005.12.059","volume":"340","author":"V.P. Garikapaty","year":"2006","unstructured":"Garikapaty VP, Ashok BT, Tadi K, et al. (2006) 3,3\u2032-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340:718\u2013725","journal-title":"Biochem Biophys Res Commun"},{"key":"795_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00007.Auborn","volume":"11","author":"M. Qi","year":"2005","unstructured":"Qi M, Anderson AE, Chen DZ, et al. (2005) Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo. Mol Med 11:59\u201363","journal-title":"Mol Med"},{"key":"795_CR49","doi-asserted-by":"crossref","first-page":"2470S","DOI":"10.1093\/jn\/133.7.2470S","volume":"133","author":"K.J. Auborn","year":"2003","unstructured":"Auborn KJ, Fan S, Rosen EM, et al. (2003) Indole-3-carbinol is a negative regulator of estrogen. J Nutr 133:2470S\u20132475S.","journal-title":"J Nutr"},{"key":"795_CR50","first-page":"1028","volume":"8","author":"B. Klencke","year":"2002","unstructured":"Klencke B, Matijevic M, Urban RG, et al. (2002) Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a phase I study of ZYC101. Clin Cancer Res 8:1028\u20131037","journal-title":"Clin Cancer Res"},{"key":"795_CR51","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1067\/mob.2003.256","volume":"188","author":"E.E. Sheets","year":"2003","unstructured":"Sheets EE, Urban RG, Crum CP, et al. (2003) Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol 188:916\u2013926","journal-title":"Am J Obstet Gynecol"},{"key":"795_CR52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","volume":"103","author":"F. Garcia","year":"2004","unstructured":"Garcia F, Petry KU, Muderspach L, et al. (2004) ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 103:317\u2013326","journal-title":"Obstet Gynecol"},{"key":"795_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s002620000125","volume":"49","author":"C. Rosales","year":"2000","unstructured":"Rosales C, Graham VV, Rosas GA, et al. (2000) A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity. Cancer Immunol Immunother 49:347\u2013360","journal-title":"Cancer Immunol Immunother"},{"key":"795_CR54","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/104303402753812520","volume":"13","author":"C.M. Corona Gutierrez","year":"2002","unstructured":"Corona Gutierrez CM, Tinoco A, Lopez Contreras M, et al. (2002) Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus. Hum Gene Ther 13:1127\u20131140","journal-title":"Hum Gene Ther"},{"key":"795_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/10430340460745757","volume":"15","author":"C.M. Corona Gutierrez","year":"2004","unstructured":"Corona Gutierrez CM, Tinoco A, Navarro T, et al. (2004) Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. Hum Gene Ther 15:421\u2013431","journal-title":"Hum Gene Ther"},{"key":"795_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/sj.cgt.7700937","volume":"13","author":"E. Garcia-Hernandez","year":"2006","unstructured":"Garcia-Hernandez E, Gonzalez-Sanchez JL, Andrade-Manzano A, et al. (2006) Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine. Cancer Gene Ther 13:592\u2013597","journal-title":"Cancer Gene Ther"},{"key":"795_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0171-2985(99)80044-8","volume":"201","author":"U. Zugel","year":"1999","unstructured":"Zugel U, Kaufmann SH (1999) Immune response against heat shock proteins in infectious diseases. Immunobiology 201:22\u201335","journal-title":"Immunobiology"},{"key":"795_CR58","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s10350-004-6229-6","volume":"45","author":"S.E. Goldstone","year":"2002","unstructured":"Goldstone SE, Palefsky JM, Winnett MT, et al. (2002) Activity of HspE7, a novel immunotherapy, in patients with anogenital warts. Dis Colon Rectum 45:502\u2013507","journal-title":"Dis Colon Rectum"},{"key":"795_CR59","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/000348940511400913","volume":"114","author":"C.S. Derkay","year":"2005","unstructured":"Derkay CS, Smith RJ, McClay J, et al. (2005) HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol 114:730\u2013737","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"795_CR60","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ygyno.2007.04.038","volume":"106","author":"M.H. Einstein","year":"2007","unstructured":"Einstein MH, Kadish AS, Burk RD, et al. (2007) Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol 106:453\u2013460","journal-title":"Gynecol Oncol"},{"key":"795_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ygyno.2007.05.038","volume":"106","author":"L.D. Roman","year":"2007","unstructured":"Roman LD, Wilczynski S, Muderspach LI, et al. (2007) A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol 106:558\u2013566","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-008-0795-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0795-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:56:19Z","timestamp":1684860979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-008-0795-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s10147-008-0795-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"12 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}